1
===============================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
-------------------------
Date of Report (Date of earliest event reported):
MARCH 9, 1998
CAMBRIDGE NEUROSCIENCE, INC.
----------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-19193 13-3319074
-------- ------- ----------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
ONE KENDALL SQUARE, BUILDING 700, CAMBRIDGE, MA 02139
-----------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 225-0600
--------------
Total Number of Pages 6.
Exhibit Index at Page 4.
================================================================================
2
ITEM 5 - OTHER EVENTS
On March 9, 1998, Cambridge NeuroScience, Inc. (the "Company") issued a
news release announcing a reduction in headcount. In addition, the Company
announced the declaration of a dividend in the amount of $1.00 per share,
payable on April 14, 1998 to holders of record on April 2, 1998. The information
contained in this news release is incorporated herein by reference and filed as
Exhibit 99.7 hereto.
ITEM 7 - FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
99.7 The Company's News Release dated March 9, 1998.
2
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CAMBRIDGE NEUROSCIENCE, INC.
Date: March 12, 1998 /s/ Harry W. Wilcox, III
------------------------
Harry W. Wilcox, III
Sr. Vice President, Finance and Business
Development; Chief Financial Officer
3
4
EXHIBIT INDEX
Exhibit
Sequential
Number Description
99.7 The Company's News Release dated March 9, 1998.
4